Press-release for stocks for LEXX

symbols : LEXX

save search

Lexaria Appoints Nelson Cabatuan as Chief Financial Officer
Published: 2024-03-14 (Crawled : 14:30) - biospace.com/
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| -50.0% | O: 0.91% H: 1.13% C: -13.29%
RIGL | $1.07 1.91% 1.87% 810K

Health Technology

| -25.52% | O: -0.69% H: 1.39% C: -7.64%
financial

Lexaria Awards Contract For Next GLP-1 Human Pilot Study
Published: 2024-03-07 (Crawled : 16:00) - biospace.com/
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| -50.89% | O: 8.93% H: 9.43% C: 2.46%
contract awards pilot study

Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1
Published: 2024-03-05 (Crawled : 16:00) - biospace.com/
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| -26.67% | O: 4.33% H: 15.34% C: 7.99%
animal diabetes study

Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Published: 2024-02-15 (Crawled : 15:30) - biospace.com/
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| -15.38% | O: 0.0% H: 1.78% C: -9.23%
nasdaq million direct offering

USD 46.90 billion growth opportunity in US-Cannabis Market between 2022 - 2027 | 21.92% YOY Growth Expected in 2023 | Technavio
Published: 2024-02-14 (Crawled : 00:00) - prnewswire.com
TCNNF | $11.42 1.06% 130K

Process Industries

| 28.16% | O: -1.19% H: 9.3% C: 4.47%
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| -15.38% | O: 0.0% H: 1.78% C: -9.23%
ACB | News | $6.46 -1.15% -1.16% 6.2M

Process Industries

| 1561.99% | O: 1.2% H: 0.5% C: -1.76%
SNDL | $1.88 2.73% 2.66% 3.2M

Process Industries

| 35.51% | O: -0.72% H: 5.55% C: 4.38%
JAZZ | $109.96 0.63% 0.63% 760K

Health Technology

| -10.06% | O: 0.26% H: 3.55% C: 3.48%
CRON | News | $2.37 -1.66% -1.69% 3.9M

Process Industries

| 14.69% | O: 0.47% H: 5.19% C: 3.77%
expected growth market

Lexaria Releases Annual Letter from the CEO - January 24, 2024
Published: 2024-01-24 (Crawled : 14:00) - biospace.com/
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| 44.74% | O: 3.29% H: 2.54% C: 0.0%
ceo

Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream
Published: 2024-01-11 (Crawled : 13:30) - globenewswire.com
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| 52.78% | O: 0.69% H: 5.52% C: 4.83%
bioscience system bloodstream

Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform
Published: 2024-01-09 (Crawled : 13:30) - globenewswire.com
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| 60.58% | O: 0.73% H: 4.86% C: 2.9%
bioscience platform

Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
Published: 2024-01-08 (Crawled : 13:30) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800

Health Technology

| 0.4% | O: 2.71% H: 0.36% C: 0.11%
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| 62.96% | O: 0.0% H: 8.15% C: 1.48%
PFE A | $26.0 2.4% -0.15% 38M

Health Technology

| -11.77% | O: -0.37% H: 1.09% C: 0.75%
NVO | News | $122.71 -0.03% 0.17% 5M

Health Technology

| 15.79% | O: 0.19% H: 0.34% C: 0.21%
MRK | News | $125.78 0.44% 0.0% 8.4M

Health Technology

| 7.3% | O: 0.32% H: 0.26% C: -0.18%
AZN | News | $68.56 0.29% 0.29% 4.7M

Health Technology

| 0.25% | O: 0.28% H: 0.99% C: 0.93%

Lexaria's Patented Technology Improved the Oral Performance of the Rybelsus(R)-Branded GLP-1 drug Semaglutide
Published: 2024-01-04 (Crawled : 00:00) - biospace.com/
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| 69.23% | O: -1.54% H: 9.38% C: 8.59%
drug technology

Lexaria's Investigational New Drug Application Filing Update
Published: 2023-12-07 (Crawled : 15:30) - biospace.com/
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| 45.7% | O: -1.32% H: 6.04% C: -3.36%
drug update application

Lexaria's Technology Improves the Oral Performance of the Rybelsus(R)-Branded GLP-1 drug Semaglutide in Human Pilot Study
Published: 2023-11-27 (Crawled : 20:00) - biospace.com/
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| 67.94% | O: 2.29% H: 35.07% C: 21.64%
drug technology pilot study

US-Cannabis Market is to grow by USD 46.90 billion between 2022 - 2027 | Rising millennial population Drive Demand for the market - Technavio
Published: 2023-11-09 (Crawled : 03:00) - prnewswire.com
TCNNF | $11.42 1.06% 130K

Process Industries

| 119.18% | O: 2.04% H: 4.0% C: -0.4%
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| 40.58% | O: 4.79% H: 0.0% C: -4.27%
ACB | News | $6.46 -1.15% -1.16% 6.2M

Process Industries

| 1246.55% | O: -4.17% H: 2.37% C: -4.09%
SNDL | $1.88 2.73% 2.66% 3.2M

Process Industries

| 27.21% | O: 0.0% H: 1.36% C: -6.12%
JAZZ | $109.96 0.63% 0.63% 760K

Health Technology

| -14.27% | O: 0.2% H: 0.56% C: -9.32%
CRON | News | $2.37 -1.66% -1.69% 3.9M

Process Industries

| 21.0% | O: 1.5% H: 1.48% C: -2.96%
market

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of Proprietary Platform in Multibillion-Dollar GLP-1 Drug Space
Published: 2023-11-01 (Crawled : 13:00) - globenewswire.com
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| 59.42% | O: 1.45% H: 3.57% C: 3.57%
drug bioscience space platform

Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-Delivery Platform for Improved Efficacy of GLP-1 Drugs
Published: 2023-10-31 (Crawled : 13:00) - globenewswire.com
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| 65.41% | O: -6.02% H: 12.0% C: 10.4%
bioscience platform

Lexaria Enters New Global Exclusive Collaboration and License Agreement with SulfoSyn
Published: 2023-10-13 (Crawled : 23:00) - biospace.com/
LEXX | $2.27 0.89% 0.88% 62K

Health Technology

| 124.51% | O: 7.15% H: 5.71% C: -12.85%
license global collaboration agreement

Lexaria Provides Update on Investigational New Drug Application Progress
Published: 2023-08-30 (Crawled : 15:00) - biospace.com/
LEXX | $2.27 0.89% 0.88% 62K

Health Technology